Stocks and Investing Stocks and Investing
Tue, February 7, 2023

Oren Livnat Reiterated (AVDL) at Strong Buy and Held Target at $13 on, Feb 7th, 2023


Published on 2024-10-28 01:24:53 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $13 on, Feb 7th, 2023.

Oren has made no other calls on AVDL in the last 4 months.



There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • Chris Howerton of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Wednesday, November 30th, 2022

Contributing Sources